2022 Fiscal Year Annual Revenue
2022 Fiscal Year Gross Profit
2022 Fiscal Year Annual Net Income
2022 Fiscal Year Gross Profit Growth
2022 Number of U.S. Stores
Leases are guaranteed by Takeda Pharmaceuticals U.S.A., Inc, which is a wholly-owned subsidiary of Takeda Pharmaceutical Co. Ltd., which is S&P Rated: Investment Grade BBB+ (Long-Term) A-2 (Short-Term)
BioLife Plasma Services is a leading company for high-quality plasma collection. A part of a global biopharmaceutical company, Takeda Pharmaceutical Compnay Limited (NYSE:TAK), BioLife continues to use high-quality plasma for the benefit of those in need. The financials and credit ratings presented are representative of the consolidated results of Takeda Pharmaceutical Company, which is BioLife Plasma Services’s parent entity.